Page last updated: 2024-11-02

pioglitazone and Cancer of Skin

pioglitazone has been researched along with Cancer of Skin in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Lipomas are common benign neoplasms of adipose tissue."1.36Letter: Iatrogenic lipomatosis: a rare manifestation of treatment with a peroxisome proliferator-activated receptor gamma agonist. ( Femia, A; Klein, PA, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Femia, A1
Klein, PA1
Coras, B1
Hafner, C1
Reichle, A1
Hohenleutner, U1
Szeimies, RM1
Landthaler, M1
Vogt, T1

Other Studies

2 other studies available for pioglitazone and Cancer of Skin

ArticleYear
Letter: Iatrogenic lipomatosis: a rare manifestation of treatment with a peroxisome proliferator-activated receptor gamma agonist.
    Dermatology online journal, 2010, Apr-15, Volume: 16, Issue:4

    Topics: Adipose Tissue; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Iatrogenic Dis

2010
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
    Archives of dermatology, 2004, Volume: 140, Issue:12

    Topics: Adult; Angiogenesis Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Endemic Diseases; Human

2004